Article Details

Cue Biopharma Receives FDA Acceptance of Investigational - GlobeNewswire

Retrieved on: 2022-05-11 12:08:14

Tags for this article:

Click the tags to see associated articles and topics

Cue Biopharma Receives FDA Acceptance of Investigational - GlobeNewswire. View article details on hiswai:

Excerpt

Cue Biopharma Receives FDA Acceptance of Investigational New Drug (IND) Application for CUE-102 in Wilms' Tumor 1 (WT1) - expressing cancers.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up